Cervical intraepithelial neoplasia grade III (CIN III) and invasive cervical carcinoma: The yawning gap revisited and the treatment of risk

Cytopathology

Volumn 10, Issue 3, 1999, Pages 161-170

  Herbert, A ^a,c   Smith, J A E ^b  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b S West Cancer Intelligence Service   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Cervical glandular intraepithelial neoplasia; Cervical intraepithelial neoplasia; Cervical screening; CGIN III; CIN III; Incidence of cervical cancer; Invasive cervical carcinoma

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER INCIDENCE; CANCER INVASION; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED KINGDOM; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; MASS SCREENING; MIDDLE AGED; REGISTRIES; UTERINE CERVICAL NEOPLASMS;

EID: 0033067413     PISSN: 09565507     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2303.1999.00169.x     Document Type: Article

References (38)

1. 1 Cruickshank ME, Angus V, Kelly M, McPhee S, Kitchener HC. The case for stopping cervical screening at age 50. Br J Obstet Gynaecol 1997; 104: 586-9.
2. 2 Hakama M, Louhivouri K. A screening programme for cervical cancer that worked. Cancer Surveys 1988; 7: 403-16.
3. 3 Macgregor JE, Moss S, Parkin DM, Day NE. Cervical cancer screening in north-east Scotland. In: Hakama M, Miller AB, Day NE, eds. Screening for Cancer of the Uterine Cervix. IARC Scientific Publications no. 76. Lyons: International Agency for Research on Cancer, 1986; 25-36.
4. 4 Peterson O. Precancerous changes of cervical epithelium in relation to manifest cervical carcinoma: clinical and histological aspects. Acta Radiol Suppl 1955; 127: 1-168.
5. 5 MacIndoe WA, MacLean MR, Jones RW. The invasive potential of carcinoma-in-situ of the cervix. Obstet Gynaecol 1984; 64: 451-8.
6. 6 Anderson MC, Cervical Precancer. In: Symmers WStC, ed. Systemic Pathology Female Reproductive System, Vol 6. Edinburgh: Churchill Livingstone, 1991.
7. 7 Miller AB. An evaluation of population screening for cervical cancer. In: Koss LG, Coleman DV, eds. Advances in Clinical Cytology. London: Butterworths, 1981; 64-94.
8. 8 Fidler HK, Boyes DA, Worth AJ. Cervical cancer detection in British Columbia: a progress report. J Obstet Gynaecol Br Commonwealth 1968; 75: 392-404.
9. 9 Boyes DA, Morrison B, Knox EG et al. A cohort study of cervical cancer screening in British Columbia. Clin Invest Med 1982; 5: 1-29.
10. 10 Anderson MC, Brown CL, Buckley CH et al. Current views on cervical intraepithelial neoplasia. J Clin Pathol 1991; 44: 9669-978.
11. 11 Brown JLR, Wells M. Cervical glandular atypia associated with squamous intraepithelial neoplasia: a premalignant lesion? J Clin Pathol 1986; 39: 22-28.
12. 12 Gloor E, Hurliman J. Cervical intraepithelial glandular neoplasia (adenocarcinoma-in-situ and glandular dysplasia). Cancer 1986; 58: 1272-80.
13. 13 Ostor AG, Pagano R, Davoren RM, Fortune DW, Chanen W, Rome R. Adenocarcinoma in situ of the cervix. Int J Gynaecol Pathol 1984; 3: 179-90.
14. 14 Cancer Research Campaign. Cervical cancer screening. Factsheet No 13.2; London: CRC, 1994.
15. 15 Herbert A, Johnson J, Patnick J et al. Achievable standards, benchmarks for reporting, criteria for evaluating cervical cytopathology. Cytopathology 1995; 6 (Suppl. 2).
16. 16 Pritchard J. Quality Assurance Guidelines for the Cervical Screening Programme. Sheffield: NHS cervical screening programme: publication No 3, January 1996.
17. 17 Herbert A, Bryant TN, Campbell MJ, Smith J. Investigation of the effect of occult invasive cancer on progress towards successful screening. J Med Screen 1998; 5: 92-8.
18. 18 Wessex Regional Health Authority. OPCS mid-year population estimates 1985 1995.
19. 19 Cervical cytology 1993/4. Summary information from Form KC 53: England. Department of Health, Statistics Division.
20. 20 Herbert A, Stein K, Bryant TN, Breen C, Old P. Relation between the incidence of invasive cervical cancer and the screening interval: is a five year interval too long? J Med Screening 1996; 3: 140-5.
21. 21 Cancer Research Campaign. Cancer of the Cervix Uteri. London: CRC Factsheet No 12.1, 1994.
22. 22 Gustafsson L, Ponten J, Bergstrom R, Adami H-O. International incidence rates of invasive cancer before cytological screening. Int J Cancer 1997; 71: 159-65.
23. 23 Herbert A. Effect of screening may be being underestimated (letter). Br Med J 1997; 314: 1277.
24. 24 Raffle AE. New tests in cervical screening (letter). Lancet 1998; 351: 297.
25. 25 Parkin DM. Screening for cervix cancer in developing countries. In: Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC, eds. Cancer Screening. Published on behalf of the International Union Against Cancer. Cambridge: Cambridge University Press, 1991: 185-98.
26. 26 Osmond C, Gardner MJ, Acheson ED, Adelstein AM. Trends in Cancer Mortality. Analyses by Period of Birth and Death. DH1, No 11, HMSO, 1988.
27. 27 Draper GJ, Cook GA. Changing patterns of cervical cancer rates. Br Med J 1983; 287: 510-2.
28. 28 Beral V, Booth M. Predictions of cervical cancer incidence and mortality in England and Wales. Lancet 1986; i: 495.
29. 29 Herbert A. Is cervical screening working? A cytopathologist's view from the UK. Hum Pathol 1997; 28: 120-6.
30. 30 Sasieni PD, Cuzick J, Lynch-Farmery E. Estimating the efficacy of screening by auditing smear histories of women with and without cancer. Br J Cancer 1996; 73: 1001-5.
31. 31 Gornal R, Boyd IE, Herbert A. Interval cancer following treatment for cervical intraepithelial neoplasia. Br J Obstet Gynaecol (submitted for publication).
32. 32 Soutler WP, de Barros Lopes, Fletcher A et al. Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia. Lancet 1997; 349: 978-80.
33. 33 Van Wijngaarden WJ, Duncan ID. Rationale for stopping cervical screening in women over 50. Br Med J 1993; 306: 967-71. [Erratum published 306, 1373].
34. 34 Gustafsson L, Sparen P, Gustafsson M et al. Low efficiency of cytologic screening for cancer in situ of the cervix in older women. Int J Cancer 1995; 63: 804-9.
35. 35 Cruikshank ME, Angus V, Kelly M et al. The case for stopping cervical screening at 50. Br J Obstet Gynaecol 1997; 104: 586-9.
36. 36 Shafi MI. Controversies in management: management of women with mild dyskaryosis. Cytological surveillance avoids overtreatment. BMJ 1994; 309: 590-1.
37. 37 Soutler WP. Controversies in management: management of women with mild dyskaryosis. Immediate referral for colposcopy is safer. BMJ 1994; 309: 591-2.
38. 38 Flannelly G, Anderson D, Kitchener HC et al. Management of women with mild and moderate dyskaryosis. Br Med J 1994; 308: 1399-403.